Program Access

Watch Now

Program Description

First-Line Maintenance Therapy for Advanced Ovarian Cancer: Pinpointing a Place for PARP Inhibitors

Dr. Alon Altman, FRCSC
University of Manitoba
CancerCare Manitoba, Shared Health
Winnipeg, Manitoba

 

Individualizing First-Line Ovarian Cancer Maintenance Therapy: A Practical Approach

Dr. Prafull Ghatage, FRCSC
University of Calgary
Tom Baker Cancer Centre
Calgary, Alberta

 

Key learning objectives:

• Summarize the rationale for using PARP inhibitors in the front-line maintenance setting for patients with advanced ovarian cancer
• Evaluate the latest evidence for current and emerging PARP inhibitors used in the front-line maintenance setting for patients with advanced ovarian cancer
• Propose strategies to individualize and optimize the use of PARP inhibitors as maintenance treatment based on patient, disease, and drug characteristics

Sponsorship

This activity is supported by an educational grant from GlaxoSmithKline Inc.

Back To Programs